Inspire Medical Systems logo
INSPInspire Medical Systems
Trade INSP now
Inspire Medical Systems primary media

About Inspire Medical Systems

Inspire Medical Systems (NYSE:INSP) specializes in developing and marketing innovative medical solutions targeted towards the treatment of obstructive sleep apnea (OSA). With a core focus on improving patient quality of life, their flagship product is a minimally invasive implantable device that works inside the body to open key airway muscles during sleep, leveraging the body’s natural breathing process. Founded with the goal of offering alternative treatments to traditional CPAP machines, Inspire aims to lead in the field of sleep disorder therapies through continuous innovation and the expansion of their product line. At the heart of their objectives is a commitment to clinical excellence, patient satisfaction, and making a positive impact on the millions suffering from sleep-related breathing issues.

What is INSP known for?

Snapshot

Public US
Ownership
2007
Year founded
1011
Employees
Minneapolis, United States
Head office
1 of 5
US Rank
Unknown
Sector
N/A
Sector rank
Loading Map...

Operations

All Locations
Minneapolis, US

Produtos e/ou serviços de Inspire Medical Systems

  • Inspire Therapy, a fully integrated obstructive sleep apnea treatment using a small device to stimulate key airway muscles.
  • Patient remote, a tool for adjusting therapy settings and managing treatment.
  • Physician's remote, enabling doctors to assess and modify therapy parameters remotely.
  • Clinical research initiatives focused on advancing sleep apnea treatment knowledge and efficacy.
  • Educational resources for patients and healthcare professionals to improve understanding and management of sleep apnea.
  • Partnerships with medical institutions for the development and testing of sleep apnea treatment technologies.

equipe executiva do Inspire Medical Systems

  • Mr. Timothy P. HerbertFounder, Chairman, CEO & President
  • Mr. Bryan K. Phillips J.D.Senior VP, General Counsel, Chief Compliance Officer & Corporate Secretary
  • Mr. Richard J. BuchholzFinancial Advisor
  • Mr. Randall A. BanEVP of Patient Access &Therapy Development
  • Mr. Carlton W. WeatherbyChief Strategy and Growth Officer
  • Mr. Jason P. KellyChief Operations and Quality Officer
  • Ms. Ezgi YagciVice President of Investor Relations
  • Ms. Melissa J. MannChief People Officer
  • Mr. John C. RondoniChief Product & Innovation Officer
  • Mr. Ivan LubogoSVP of Strategic Sales

Connect with us

Disclaimer

Grafa is not a financial advisor. You should seek independent, legal, financial, taxation or other advice that relate to your unique circumstances.

Grafa is not liable for any loss caused, whether due to negligence or otherwise arising from the use of or reliance on the information provided directly or indirectly, by use of this platform.